<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39451643</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4418</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Diagnostics (Basel, Switzerland)</Title><ISOAbbreviation>Diagnostics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Blood Eosinophils Matter in Post-COVID-19 Pneumonia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/diagnostics14202320</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Even after the development of vaccines, SARS-CoV-2 continues to cause severe pneumonia all over the world. Consequently, in order to improve the management of patients and optimize the use of resources, predictors of disease severity and lung complications after COVID-19 pneumonia are urgently needed. Blood cell count is an easily available and reproducible biomarker. With this study, we aimed to explore the role of eosinophils in predicting disease behavior and pulmonary sequelae at first follow-up with computed tomography (CT).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">we evaluated blood cell count and other inflammatory markers, both at baseline and during hospitalization, in a large population of hospitalized COVID-19 patients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">327 patients were finally enrolled, 214 were classified as low-intensity medical care (LIMC) and 113 as high-intensity medical care. Eosinophils were higher at discharge in the HIMC group [0.1 (0-0.72) vs. 0.05 (0-0.34) × 109/L; <i>p</i> &lt; 0.0001]. Moreover, in the multivariable analysis, age ≥ 62 years (OR 1.76 (1.05-2.8) <i>p</i> = 0.03) and Δ eosinophils ≥ 0.05 (OR 1.75 (1.05-2.9) <i>p</i> = 0.03) were two independent predictors of residual lung abnormalities in the whole patient population at first follow-up.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">an eosinophil increase during hospitalization could be a potential predictor of pulmonary sequelae in surviving patients after COVID-19 pneumonia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bernardinello</LastName><ForeName>Nicol</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castelli</LastName><ForeName>Gioele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5925-4035</Identifier><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasin</LastName><ForeName>Dylan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grisostomi</LastName><ForeName>Giulia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cola</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Internal Medicine, Azienda Ospedaliera Universitaria di Padova, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giraudo</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-0924-5883</Identifier><AffiliationInfo><Affiliation>Department of Cardiac, Thoracic, Vascular Sciences, and Public Health, University of Padova, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cocconcelli</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cattelan</LastName><ForeName>Annamaria</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2869-2945</Identifier><AffiliationInfo><Affiliation>Infectious Diseases Unit, Department of Internal Medicine, Azienda Ospedaliera Universitaria di Padova, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spagnolo</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-1096-0596</Identifier><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balestro</LastName><ForeName>Elisabetta</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-1373-8197</Identifier><AffiliationInfo><Affiliation>Respiratory Disease Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, Padova University Hospital, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Diagnostics (Basel)</MedlineTA><NlmUniqueID>101658402</NlmUniqueID><ISSNLinking>2075-4418</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pneumonia</Keyword><Keyword MajorTopicYN="N">chest CT scan</Keyword><Keyword MajorTopicYN="N">eosinophils</Keyword><Keyword MajorTopicYN="N">lung abnormalities</Keyword><Keyword MajorTopicYN="N">prognostic markers</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest regarding this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>9</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>18</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39451643</ArticleId><ArticleId IdType="pmc">PMC11506628</ArticleId><ArticleId IdType="doi">10.3390/diagnostics14202320</ArticleId><ArticleId IdType="pii">diagnostics14202320</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cocconcelli E., Biondini D., Giraudo C., Lococo S., Bernardinello N., Fichera G., Barbiero G., Castelli G., Cavinato S., Ferrari A., et al. Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19. J. Clin. Med. 2020;9:2990. doi: 10.3390/jcm9092990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092990</ArticleId><ArticleId IdType="pmc">PMC7565657</ArticleId><ArticleId IdType="pubmed">32947904</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.-B., Hu L., Ming Q., Wei X.-J., Zhang Z.-Y., Chen L.-D., Wang M.-H., Yao W.-Z., Huang Q.-F., Ye Z.-Q., et al. Risk factors for mortality of coronavirus disease-2019 (COVID-19) patients in two centers of Hubei province, China: A retrospective analysis. PLoS ONE. 2021;16:e0246030. doi: 10.1371/journal.pone.0246030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246030</ArticleId><ArticleId IdType="pmc">PMC7842894</ArticleId><ArticleId IdType="pubmed">33507974</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno S., Ventura P.S., Castellano J.M., García-Adasme S.I., Miranda M., Touza P., Lllana I., López-Escobar A. Prognostic implications of neutrophil-lymphocyte ratio in COVID-19. Eur. J. Clin. Investig. 2021;51:e13404. doi: 10.1111/eci.13404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13404</ArticleId><ArticleId IdType="pubmed">32918295</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Sang L., Jiang M., Yang Z., Jia N., Fu W., Xie J., Guan W., Liang W., Ni Z., et al. Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J. Allergy Clin. Immunol. 2020;146:89–100. doi: 10.1016/j.jaci.2020.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7212968</ArticleId><ArticleId IdType="pubmed">32407836</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B., Yang J., Xie Y., Tang X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J. 2021;14:100521. doi: 10.1016/j.waojou.2021.100521.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2021.100521</ArticleId><ArticleId IdType="pmc">PMC7877210</ArticleId><ArticleId IdType="pubmed">33589865</ArticleId></ArticleIdList></Reference><Reference><Citation>Palladino M. Complete blood count alterations in COVID-19 patients: A narrative review. Biochem. Med. 2021;31:030501. doi: 10.11613/BM.2021.030501.</Citation><ArticleIdList><ArticleId IdType="doi">10.11613/BM.2021.030501</ArticleId><ArticleId IdType="pmc">PMC8495616</ArticleId><ArticleId IdType="pubmed">34658642</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavezzo E., Pacenti M., Manuto L., Boldrin C., Cattai M., Grazioli M., Bianca F., Sartori M., Caldart F., Castelli G., et al. Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history. Genome Med. 2022;14:61. doi: 10.1186/s13073-022-01066-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-022-01066-2</ArticleId><ArticleId IdType="pmc">PMC9185135</ArticleId><ArticleId IdType="pubmed">35689243</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocconcelli E., Bernardinello N., Giraudo C., Castelli G., Giorgino A., Leoni D., Petrarulo S., Ferrari A., Saetta M., Cattelan A., et al. Characteristics and Prognostic Fac-tors of Pulmonary Fibrosis After COVID-19 Pneumonia. Front. Med. 2022;8:823600. doi: 10.3389/fmed.2021.823600.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.823600</ArticleId><ArticleId IdType="pmc">PMC8841677</ArticleId><ArticleId IdType="pubmed">35174188</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagunas-Rangel F.A. Neutrophil-to-lymphocyte ratio and lymphocyte- C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis. J. Med. Virol. 2020;92:1733–1734. doi: 10.1002/jmv.25819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25819</ArticleId><ArticleId IdType="pmc">PMC7228336</ArticleId><ArticleId IdType="pubmed">32242950</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyit M., Avci E., Nar R., Senol H., Yilmaz A., Ozen M., Oskay A., Aybek H. Neutrophil to lymphocyte ratio, lym-phocyte to monocyte ratio, and platelet to lymphocyte ratio to predict the severity of COVID-19. Am. J. Emerg. Med. 2021;40:110–114. doi: 10.1016/j.ajem.2020.11.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.11.058</ArticleId><ArticleId IdType="pmc">PMC7719281</ArticleId><ArticleId IdType="pubmed">33309506</ArticleId></ArticleIdList></Reference><Reference><Citation>Davoine F., Lacy P. Eosinophil cytokines, chemokines, and growth factors: Emerging roles in immunity. Front. Immunol. 2014;5:570. doi: 10.3389/fimmu.2014.00570.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00570</ArticleId><ArticleId IdType="pmc">PMC4225839</ArticleId><ArticleId IdType="pubmed">25426119</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer L.A., Szela C.T., Perez S.A.C., Kirchhoffer C.L., Neves J.S., Radke A.L., Weller P.F. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 2008;85:117–123. doi: 10.1189/jlb.0108058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0108058</ArticleId><ArticleId IdType="pmc">PMC2626765</ArticleId><ArticleId IdType="pubmed">18840671</ArticleId></ArticleIdList></Reference><Reference><Citation>Chitkara R.K., Krishna G. Parasitic pulmonary eosinophilia. Semin. Respir Crit Care Med. 2006;27:171–184. doi: 10.1055/s-2006-939520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2006-939520</ArticleId><ArticleId IdType="pubmed">16612768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigo-Muñoz J., Sastre B., Cañas J., Gil-Martínez M., Redondo N., del Pozo V. Eosinophil response against classical and emerging respiratory viruses: COVID-19. J. Investig. Allergol. Clin. Immunol. 2021;31:94–107. doi: 10.18176/jiaci.0624.</Citation><ArticleIdList><ArticleId IdType="doi">10.18176/jiaci.0624</ArticleId><ArticleId IdType="pubmed">32540792</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler M.E., Munitz A., Ackerman S.J., Drake M.G., Jackson D.J., Wardlaw A.J., Dougan S.K., Berdnikovs S., Schleich F., Matucci A., et al. Eosinophils in Health and Disease: A State-of-the-Art Review. Mayo Clin. Proc. 2021;96:2694–2707. doi: 10.1016/j.mayocp.2021.04.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.04.025</ArticleId><ArticleId IdType="pubmed">34538424</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui S., Bachert C., Bjermer L., Buchheit K.M., Castro M., Qin Y., Rupani H., Sagara H., Howarth P., Taillé C. Eosinophils and tissue remodeling: Relevance to airway disease. J. Allergy Clin. Immunol. 2023;152:841–857. doi: 10.1016/j.jaci.2023.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2023.06.005</ArticleId><ArticleId IdType="pubmed">37343842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraiss’e M., Logre E., Mentec H., Cally R., Plantef G., Contou D. Eosinophilia in critically ill COVID-19 patients: A French monocenter retrospective study. Crit. Care. 2020;24:e13404. doi: 10.1186/s13054-020-03361-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03361-z</ArticleId><ArticleId IdType="pmc">PMC7607895</ArticleId><ArticleId IdType="pubmed">33143729</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y., Tu L., Zhu P., Mu M., Wang R., Yang P., Wang X., Hu C., Ping R., Hu P., et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A ret-rospective observational study. Am. J. Respir. Crit. Care Med. 2020;201:1372–1379. doi: 10.1164/rccm.202003-0543OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202003-0543OC</ArticleId><ArticleId IdType="pmc">PMC7258652</ArticleId><ArticleId IdType="pubmed">32242738</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanni F., Akker E., Zaman M.M., Figueroa N., Tharian B., Hupart K.H. Eosinopenia and COVID-19. J. Am. Osteopath. Assoc. 2016;20:091. doi: 10.7556/jaoa.2020.091.</Citation><ArticleIdList><ArticleId IdType="doi">10.7556/jaoa.2020.091</ArticleId><ArticleId IdType="pubmed">32672799</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y., Zhou J., Zhou Q., Hu L., Long Y. Role of eosinophils in the diagnosis and prognostic evaluation of COVID-19. J. Med. Virol. 2020;93:1105–1110. doi: 10.1002/jmv.26506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26506</ArticleId><ArticleId IdType="pubmed">32915476</ArticleId></ArticleIdList></Reference><Reference><Citation>Macchia I., La Sorsa V., Urbani F., Moretti S., Antonucci C., Afferni C., Schiavoni G. Eosinophils as potential biomarkers in respiratory viral infections. Front. Immunol. 2023;14:1170035. doi: 10.3389/fimmu.2023.1170035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1170035</ArticleId><ArticleId IdType="pmc">PMC10358847</ArticleId><ArticleId IdType="pubmed">37483591</ArticleId></ArticleIdList></Reference><Reference><Citation>Gieseck R.L., 3rd, Wilson M.S., Wynn T.A. Type 2 immunity in tissue repair and fibrosis. Nat. Rev. Immunol. 2018;18:62–76. doi: 10.1038/nri.2017.90.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2017.90</ArticleId><ArticleId IdType="pubmed">28853443</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolahian S., Fernandez I.E., Eickelberg O., Hartl D. Immune mechanisms in pulmonary fibrosis. Am. J. Respir. Cell Mol. Biol. 2016;55:309–322. doi: 10.1165/rcmb.2016-0121TR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2016-0121TR</ArticleId><ArticleId IdType="pubmed">27149613</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z.L., Chen C., Huang L., Zhou S.C., Hu Y.N., Xia L.M., Li Y. Fibrotic changes depicted by thin-section CT in patients with COVID-19 at the early recovery stage: Preliminary experience. Front. Med. 2020;7:605088. doi: 10.3389/fmed.2020.605088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.605088</ArticleId><ArticleId IdType="pmc">PMC7732534</ArticleId><ArticleId IdType="pubmed">33330571</ArticleId></ArticleIdList></Reference><Reference><Citation>Toraldo D.M., Satriano F., Rollo R., Verdastro G., Imbriani G., Rizzo E., Argentiero A., Falco A., Ambrosino P., Miani A., et al. COVID-19 IgG/IgM patterns, early IL-6 elevation and long-term radiological sequelae in 75 patients hospitalized due to interstitial pneumonia followed up from 3 to 12 months. PLoS ONE. 2022;17:e0262911. doi: 10.1371/journal.pone.0262911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0262911</ArticleId><ArticleId IdType="pmc">PMC8863277</ArticleId><ArticleId IdType="pubmed">35192635</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C., Wong P., Klein J., Castro T.B.R., Silva J., Sundaram M., Ellingson M.K., Mao T., Oh J.E., Israelow B., et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. 2020;584:463–469. doi: 10.1038/s41586-020-2588-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Huaux F., Liu T., McGarry B., Ullenbruch M., Xing Z., Phan S.H. Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis. J. Immunol. 2003;171:5470–5481. doi: 10.4049/jimmunol.171.10.5470.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.10.5470</ArticleId><ArticleId IdType="pubmed">14607953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock A., Rabe K.F., Dent G., Chambers R.C., Gray A.J., Chung K.F., Barnes P.J., Laurent G.J. Eosinophils adhere to and stimulate replication of lung fibroblasts ‘in vitro’. Clin. Exp. Immunol. 1991;86:185–190. doi: 10.1111/j.1365-2249.1991.tb05793.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.1991.tb05793.x</ArticleId><ArticleId IdType="pmc">PMC1554162</ArticleId><ArticleId IdType="pubmed">1914231</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen J., Armstrong B.S., Cowman S., Tomer Y., Veerabhadraiah S.R., Beers M.F., Venosa A. Immunophenotyping of Acute Inflammatory Exacerba-tions of Lung Injury Driven by Mutant Surfactant Protein-C: A Role for Inflammatory Eosinophils. Front. Pharmacol. 2022;13:875887. doi: 10.3389/fphar.2022.875887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.875887</ArticleId><ArticleId IdType="pmc">PMC9094740</ArticleId><ArticleId IdType="pubmed">35571100</ArticleId></ArticleIdList></Reference><Reference><Citation>Biondini D., Balestro E., Sverzellati N., Cocconcelli E., Bernardinello N., Ryerson C.J., Spagnolo P. Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF): An overview of current and future therapeutic strategies. Expert Rev. Respir. Med. 2020;14:405–414. doi: 10.1080/17476348.2020.1724096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17476348.2020.1724096</ArticleId><ArticleId IdType="pubmed">31994940</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakugawa T., Sakamoto N., Sato S., Yura H., Harada T., Nakashima S., Hara A., Oda K., Ishimoto H., Yatera K., et al. Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis. Respir. Res. 2016;17:79. doi: 10.1186/s12931-016-0400-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-016-0400-1</ArticleId><ArticleId IdType="pmc">PMC4940941</ArticleId><ArticleId IdType="pubmed">27401332</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukema B.N., Smit K., Hopman M.T.E., Bongers C.C.W.G., Pelgrim T.C., Rijk M.H., Platteel T.N., Venekamp R.P., Zwart D.L.M., Rutten F.H., et al. Neutrophil and Eo-sinophil Responses Remain Abnormal for Several Months in Primary Care Patients With COVID-19 Disease. Front. Allergy. 2022;3:942699. doi: 10.3389/falgy.2022.942699.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/falgy.2022.942699</ArticleId><ArticleId IdType="pmc">PMC9365032</ArticleId><ArticleId IdType="pubmed">35966226</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa V., Gal A., De Menezes D.C., De Lima L., Regina V., Pal M., Vasconcelos P.F.d.C., Quaresma J.A.S., Falcão L.F.M. Evaluation of the hematological patterns from up to 985 days. Viruses. 2023;15:879. doi: 10.3390/v15040879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040879</ArticleId><ArticleId IdType="pmc">PMC10142608</ArticleId><ArticleId IdType="pubmed">37112859</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Sivan M., Perlowski A., Nikolich J.Ž. Long COVID: A clinical update. Lancet. 2024;404:707–724. doi: 10.1016/S0140-6736(24)01136-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01136-X</ArticleId><ArticleId IdType="pubmed">39096925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>